about
Comparison of renal response to four different induction therapies in Japanese patients with lupus nephritis class III or IV: A single-centre retrospective study.Renal protective effect of antiplatelet therapy in antiphospholipid antibody-positive lupus nephritis patients without antiphospholipid syndrome.A positive direct Coombs' test in the absence of hemolytic anemia predicts high disease activity and poor renal response in systemic lupus erythematosusLow additive effect of hydroxychloroquine on Japanese patients with systemic lupus erythematosus taking calcineurin inhibitorLow-dose rituximab as induction therapy for ANCA-associated vasculitisA low perfusion-metabolic mismatch in 99m Tl and 123 I-BMIPP scintigraphy predicts poor prognosis in systemic sclerosis patients with asymptomatic cardiac involvementMycophenolate mofetil treatment with or without a calcineurin inhibitor in resistant inflammatory myopathyHigh plasma mycophenolate acid concentration in the early phase of induction therapy predicts good renal outcome in lupus nephritisGlucocorticoid, immunosuppressant, hydroxychloroquine monotherapy, or no therapy for maintenance treatment in systemic lupus erythematosus without major organ manifestations
P50
Q36338094-89B0C268-B29E-4924-90CB-B9BA5E47EBD4Q55232005-C4F37873-5AE7-4428-B78C-BA578BF98A00Q57788099-0131FF08-1D4A-4182-9A27-8B0647B98CB2Q58581680-8560B0FE-70C0-4DA5-9EAF-7880F41BF06CQ91214607-BAFC156D-1E7F-4A6E-84FE-2359A3C5C36DQ91392793-E3534381-0803-4597-B17D-592D220395EDQ91459911-59B1CC36-E39D-45E4-9717-5B9D1A7AA956Q92335568-C0615167-9870-4A0E-850B-884C8661769FQ92597452-70B01583-C3B0-41D8-AE6B-214C58D9A43A
P50
description
researcher
@en
name
Hironari Hanaoka
@en
type
label
Hironari Hanaoka
@en
prefLabel
Hironari Hanaoka
@en
P31
P496
0000-0002-5172-1102